| Name | Title | Contact Details |
|---|
InnFocus, Inc., an early stage company pioneering a microsurgical solution for glaucoma.InnFocus is an ophthalmology company founded in 2003 with extensive biomaterials experience that develops and provides next generation products for glaucoma surgery. Glaucoma is a disease for which there is no cure, is the second leading cause of blindness in the world and afflicts an estimated 60 million people worldwide.
MedPoint is focused on innovative, high-value services. We are a global best-in-class company in our service areas. We work with clients on new approaches to training, education and communications that work in the real world of medicine.
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Twin Health invented the Whole Body Digital Twin™ to help reverse and prevent chronic metabolic diseases, improve energy and physical health, and extend lifespan. We combine advanced technology and medical science to heal the most complex and dynamic system of all—the human metabolism. Twin is headquartered in California, USA and Chennai, India. Twin Health does not interview prospective employees via any apps, nor will we ask you to purchase equipment or provide financial information prior to joining.
Care Access Health Plan is a Hallandale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.